Increased Prevalence of Pediatric Pneumococcal Serotypes in Elderly Adults
Open Access
- 15 August 2005
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 41 (4) , 481-487
- https://doi.org/10.1086/432015
Abstract
Background. Pneumococcal disease is most prevalent among young children and elderly adults. We explored whether similarities exist in the serotypes that cause disease in these 2 high-risk groups. Methods. With use of US population-based data from 1998–1999 (before the introduction of the 7-valent pneumococcal conjugate vaccine [PCV7] as routine immunization for infants) from the Centers for Disease Control and Prevention's Active Bacterial Core surveillance, we evaluated whether the rate of invasive pneumococcal disease caused by the pediatric serotypes (6B, 9V, 14, 19F, and 23F) increased among elderly persons. We adjusted for potential confounders in multivariable logistic regression. Results. We analyzed 2987 pneumococcal isolates recovered from adults. The risk of infection with pediatric serotypes increased from 32.5% in 35–49-year-old persons to 51.2% in ⩾85-year-old persons (P < .001). Compared with 35–49-year-old persons, the risk of infection with pediatric serotypes was significantly elevated among 65–74-year-old persons (relative risk [RR], 1.68; 95% confidence interval [CI], 1.29–2.20) and increased progressively among persons aged 75–84 years (RR, 1.82; 95% CI, 1.41–2.36) and ⩾85 years (RR, 2.29; 95% CI, 1.72–3.05), with adjustment for sex, race, geographic location, underlying illness, and penicillin resistance. The rate of penicillin resistance was also elevated in the elderly population but was not significant after adjustment for serotype and race. Conclusions. The increased proportion of severe pneumococcal disease caused by pediatric serotypes in the elderly population might indicate opportunities for prevention with use of PCV7.Keywords
This publication has 25 references indexed in Scilit:
- Invasive Pneumococcal Disease in Scotland, 1999-2001: Use of Record Linkage to Explore Associations between Patients and Disease in Relation to Future Vaccination PolicyClinical Infectious Diseases, 2003
- Multistate Evaluation of Invasive Pneumococcal Diseases in Adults with Human Immunodeficiency Virus Infection: Serotype and Antimicrobial Resistance Patterns in the United StatesThe Journal of Infectious Diseases, 2003
- Historical Changes in Pneumococcal Serogroup Distribution: Implications for the Era of Pneumococcal Conjugate VaccinesClinical Infectious Diseases, 2002
- Epidemiology of Invasive Streptococcus pneumoniae Infections in the United States, 1995-1998Opportunities for Prevention in the Conjugate Vaccine EraJAMA, 2001
- Geographical differences in invasive pneumococcal disease rates and serotype frequency in young childrenThe Lancet, 2001
- Increasing Prevalence of Multidrug-ResistantStreptococcus pneumoniaein the United StatesNew England Journal of Medicine, 2000
- Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997American Journal of Public Health, 2000
- Which Pneumococcal Serogroups Cause the Most Invasive Disease: Implications for Conjugate Vaccine Formulation and Use, Part IClinical Infectious Diseases, 2000
- Streptococcus pneumoniaeBlood Culture Isolates from Patients with and without Human Immunodeficiency Virus Infection: Alterations in Penicillin Susceptibilities and in Serogroups or SerotypesClinical Infectious Diseases, 1997
- Serogroup-Specific Epidemiology of Streptococcus pneumoniae: Associations with Age, Sex, and Geography in 7,000 Episodes of Invasive DiseaseClinical Infectious Diseases, 1996